Kapila v. Warburg Pincus, LLC (In re Universal Health Care Group, Inc.)
560 B.R. 594
Bankr. M.D. Fla.2016Background
- Universal Health Care Group (holding company) and regulated Medicare HMO subsidiaries collapsed; Chapter 11 filed Feb 6, 2013 and trustee appointed after failed § 363 sale.
- In 2006 Warburg Pincus Private Equity IX, L.P. (Equity IX) and Allen Wise bought Series A preferred stock with a redemption right exercisable Aug 17, 2011; Equity IX had board veto rights and placed Warburg’s principal Alok Sanghvi on Universal’s board.
- Warburg’s internal valuations (by 2009) substantially discounted Equity IX’s stake (e.g., $23.9M total equity, later $5M for Equity IX), while Universal’s audited statements purported healthier results.
- In Feb 2011 Universal borrowed $37.5M (senior secured) and used proceeds to redeem Equity IX’s and Wise’s preferred shares early for a combined ~$33.4M (discount from ~ $60M mandatory redemption six months later).
- Trustee alleges the redemption (and attendant secured debt) rendered Universal insolvent or worsened insolvency, and that Warburg/Sanghvi withheld adverse valuations while negotiating — claims brought: fraudulent transfer (bankruptcy and Florida law) and breaches of fiduciary duty (and respondeat superior for Warburg).
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Insolvency for fraudulent-transfer avoidance | Redemption and new $37.5M secured loan rendered or revealed insolvency; Warburg knew true valuations showing low equity | Lenders’ willingness to extend $37.5M (and later $60M facility) shows debtor was creditworthy and not insolvent; dismissal required | Denied dismissal — insolvency is a factual issue; complaint plausibly alleges insolvency and fair valuation disputes that preclude dismissal |
| Reasonably equivalent value (constructive fraud) | Universal received less than reasonably equivalent value because stock redemption removed equity and added secured debt; negotiations were conflicted and valuation concealed | Redemption was an arm’s-length negotiated discount that saved Universal ~$28M vs mandatory redemption — hence reasonably equivalent value | Denied dismissal — plaintiff plausibly alleged lack of reasonably equivalent value and unfairness; factual issues for discovery |
| Fiduciary duty of Sanghvi (dual roles) and Warburg liability | Sanghvi (Warburg principal and Universal director) owed loyalty and allegedly withheld Warburg valuations, inducing an unfair redemption; Warburg liable under respondeat superior | Sanghvi a minority-designee director who owed no broader duties; any pre-closing claims released by Stock Redemption Agreement | Denied dismissal — complaint alleges facts showing control/leverage, non-disclosure, insolvent transaction, and a post-closing bonus; release may be void if transaction avoided; claims plausible |
| Release defense (Section 4.5) | Release is limited and cannot bar claims based on fraud/non-disclosure or claims that invalidate the transaction; release does not necessarily discharge other tortfeasors | Release covers acts/omissions prior to closing and thus bars trustee’s claims | Denied dismissal — release is an affirmative defense not shown to bar claims on face of complaint; avoidance would nullify the release |
Key Cases Cited
- Ashcroft v. Iqbal, 556 U.S. 662 (pleading standard: plausibility required to survive 12(b)(6))
- Bell Atlantic Corp. v. Twombly, 550 U.S. 544 (pleading standard and ‘‘plausibility’’ framework)
- Weinberger v. UOP, 457 A.2d 701 (Del. 1983) (conflicted director transactions must meet entire-fairness standard)
- In re Hechinger Inv. Co. of Del., 274 B.R. 71 (D. Del. 2002) (Delaware law: fiduciary duties owed by directors/officers/controlling shareholders)